Details for Patent: 6,004,973

✉ Email this page to a colleague

Summary for Patent: 6,004,973

Title:	Pharmaceutical compositions comprising rafamycin coprecipitates
Abstract:	Disclosed are pharmaceutical compositions containing solid dispersions in the form of co-precipitates, which solid dispersions contain rapamycin and a carrier medium, and methods of treatment utilizing such pharmaceutical compositions.
Inventor(s):	Guitard; Patrice (Hegenheim, FR), Haeberlin; Barbara (Riehen, CH), Link; Rainer (Staufen, DE), Richter; Friedrich (Grenzach-Wyhlen, DE)
Assignee:	Novartis AG (Basel, CH)
Application Number:	08/981,952
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 6,004,973
Patent Claim Types: see list of patent claims	Composition; Use;

Drugs Protected by US Patent 6,004,973

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 6,004,973

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	9514397	Jul 14, 1995
United Kingdom	9515025	Jul 21, 1995

PCT Information
PCT Filed	July 12, 1996	PCT Application Number:	PCT/EP96/03066
PCT Publication Date:	February 06, 1997	PCT Publication Number:	WO97/03654

International Family Members for US Patent 6,004,973

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	258429	⤷ Sign Up
Austria	310519	⤷ Sign Up
Australia	6615296	⤷ Sign Up
Australia	706174	⤷ Sign Up
Belgium	1009856	⤷ Sign Up
Brazil	9609537	⤷ Sign Up
Canada	2225960	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.